Document Detail


ABO blood groups and thrombosis: a causal association, but is there value in screening?
MedLine Citation:
PMID:  21453026     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
ABO(H) antigens are expressed on red cells and on von Willebrand factor. An association between groups other than O and thrombosis exists: an effect that is predominantly mediated by von Willebrand factor. Overall, the risk of venous thrombosis associated with non-O has been estimated at 1.75-fold, with a higher risk (∼2.4-fold) in those with the least O(H) antigen (a combined group of A(1)A(1)/A(1)B/BB). Preliminary evidence also suggests that blood group may influence the venous thromboembolism risk associated with factor V Leiden. Overall, ABO(H) has a more modest effect on arterial disease, with a consistent effect observed in peripheral vascular disease and no influence evident with angina. A modest effect on myocardial infarction and stroke has been reported in some but not all studies. The potential mechanisms whereby blood group influences thrombosis, the limitations of current evidence and the current and future role of blood groups in identifying those at risk of arterial and venous disease is discussed.
Authors:
Peter Clark; Olivia Wu
Related Documents :
3549706 - Use of arteriovenous shunts and right atrial catheters for daily granulocyte collection.
1439976 - Risk factors for hepatitis b carrier status among blood donors of the national blood ce...
17707696 - Availability of blood components and plasma derived medicines in iran.
10681726 - Prevalence of tt viral dna in italian blood donors with and without elevated serum alt ...
2980806 - Mercury in whole blood of persons living in a polluted region of turkey.
20930076 - Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for trea...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Future cardiology     Volume:  7     ISSN:  1744-8298     ISO Abbreviation:  Future Cardiol     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-04-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101239345     Medline TA:  Future Cardiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  191-201     Citation Subset:  IM    
Affiliation:
Department of Transfusion Medicine, East of Scotland Blood Transfusion Centre, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. peterclark@nhs.net.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myocardial ischemia: a silent epidemic in Type 2 diabetes patients.
Next Document:  Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death.